Shanghai Bio-heart Biological Technology Co., Ltd. (02185.HK) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 5Aug 10Aug 13Aug 18Aug 21Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−3.0x

Market Cap

HKD 441.80M

MomentumView details →

1D Return

−0.55%

YTD Return

−68.65%

RSI (14)

36.2

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−3.0x

Market Cap

HKD 441.80M

RSI (14)

36.2

MomentumView details →

1D Return

−0.55%

YTD Return

−68.65%

ProfitabilityView details →

Gross Margin

15.03%

Net Margin

−278.77%

EBITDA Margin

−188.13%

ROE (TTM)

−40.70%

ROA (TTM)

−20.70%

Asset Turnover

0.07x

GrowthView details →

Revenue YoY

—

EPS YoY

+33.93%

FCF YoY

+69.03%

Revenue CAGR 3Y

—

EPS CAGR 3Y

+22.22%

EBITDA YoY

+52.46%

EarningsView details →

EPS (Actual)

−HKD 0.15

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Capital & dividendView details →

Debt/Equity

0.03x

Current Ratio

23.75x

Quick Ratio

21.50x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

Financials snapshotView financials →

Revenue (TTM)

58.71M

Net Income (TTM)

−163.66M

Op. CF (TTM)

—

Next earningsMar 26, 2027 →

Latest newsMore news →

No recent news for 02185.HK.

Similar companies

Vogenx Inc.VOGX Rezolute, Inc.RZLT BioAge Labs, Inc.BIOA Evommune, Inc.EVMN Genfit S.A.GNFT Prelude Therapeutics IncorporatedPRLD Find similar companies →

Latest newsMore news →

No recent news for 02185.HK.